)

Absci (ABSI) investor relations material
Absci H.C. Wainwright 27th Annual Global Investment Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Platform and business strategy
Focuses on AI-driven generative design for novel antibody therapeutics, targeting hard-to-drug biologics rather than small molecules.
Differentiates by integrating wet lab validation with rapid, scalable data generation and screening for protein-protein interactions.
Strategic shift from early-stage partnerships to advancing internal pipeline assets further before partnering, aiming for higher deal values.
Maintains a partnership model but now seeks to partner at later development stages or commercialize select assets independently.
Expects to announce a new large pharma partnership within the year, separate from internal program deals.
Pipeline highlights and clinical development
ABS201 targets the prolactin receptor for androgenetic alopecia, aiming for a convenient, durable injectable treatment with broad patient applicability.
Preclinical data in non-human primates show durable hair regrowth after limited dosing, supporting the product's design for infrequent administration.
Phase 1/2A trial for ABS201 expected to start in early 2026 or sooner, with interim proof-of-concept data anticipated in the second half of next year.
ABS101, targeting TL1A for IBD, is in phase 1 with interim data expected in the second half of this year; designed for higher affinity, potency, and convenient subcutaneous dosing.
Plans to partner ABS101 after phase 1 interim results, with ongoing discussions and sufficient capital to advance further if needed.
Competitive positioning and market opportunity
ABS201 offers potential advantages over competitors, including superior stability, solubility, extended half-life, and fewer required doses.
Market for androgenetic alopecia is large, with 80 million affected in the U.S.; product positioned for cash-pay model due to limited insurance coverage.
Existing treatments for hair loss have limited efficacy, poor adherence, or side effects, highlighting unmet need for a safe, convenient, and effective option.
ABS101 aims to differentiate from first-generation anti-TL1A antibodies with improved pharmacokinetics and dosing convenience.
Both internal and partnered programs are expected to drive near-term value inflection points.
Next Absci earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage